• Find a pharmacy

There’s an important way to catch up with your kids

Watch our story
Play icon
Your child likely received their hepatitis B vaccine at birth, but if you were born before 1991, you may be living unprotected

Now the CDC says it’s time for adults to get caught up, and HEPLISAV-B is here to help

HEPLISAV-B is the first and only adult hepatitis B vaccine that can get you caught up with just 2 doses in 1 month. Ask your pharmacist about HEPLISAV-B.
Locate a pharmacy
Mom looks into camera while son makes lemonade
Beginning in 1991, hepatitis B vaccination became standard of care for infants, making it the first shot your baby likely received before leaving the hospital.

Now the CDC recommends hepatitis B vaccination for all adults aged 19-59*

Yes, that means you. It can be difficult to juggle all that life throws at you, but it’s important to prioritize your health by getting caught up on your hepatitis B vaccination status.
Getting vaccinated can be simple

There is no cure for hepatitis B—prevention is essential

Hepatitis B is an incurable liver infection caused by the hepatitis B virus. When the virus attacks the liver, the resulting health complications can be lifelong or even deadly.
More about hepatitis B
Hepatitis B virus icon
Mom and  daughter play with building blocks
There is no cure for hepatitis B

The good news is that hepatitis B is preventable with vaccination

Get protected today
HEPLISAV-B® Hepatitis B Vaccine (Recombinant), Adjuvanted logo

The first and only adult hepatitis B vaccine that's just
2 doses in 1 month—done!

Box with checkmark icon

It’s essential to
complete all doses

of any hepatitis B vaccine to be protected
Calendar icon

All other adult hepatitis B vaccines require at least 3 doses over 6 months to complete

(who needs an extra task lingering on their to-do list for 6 whole months?!)
Shield icon with medical cross
With just 2 doses in 1 month,

HEPLISAV-B offers faster and higher rates of protection

without having to flip through your calendar
Coverage information
Most insurance plans cover HEPLISAV-B. Ask your doctor or pharmacist about vaccination coverage and reimbursement to learn more.
Don’t miss a dose
You’ve got a lot to keep track of—let us handle this one. Sign up to get text reminders for your first or second dose.
The CDC also recommends hepatitis B vaccination for adults aged ≥60 with risk factors. Adults aged ≥60 without risk factors may receive hepatitis B vaccination.CDC, Centers for Disease Control and Prevention.
INDICATION & Important Safety Information

INDICATION

HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older.

IMPORTANT SAFETY INFORMATION

If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B.

HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction.

If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection.

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Please see full Prescribing Information.

INDICATION & Important Safety Information

INDICATION

HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older.

IMPORTANT SAFETY INFORMATION

If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B.

HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction.

If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection.

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Please see full Prescribing Information.

This website is intended for US audiences only.